Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccines and therapeutics for immunocompromised patients with COVID-19
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study
Rachael A. Evans, Sabada Dube, Yi Lu, et al.
The Lancet Regional Health - Europe (2023) Vol. 35, pp. 100747-100747
Open Access | Times Cited: 81
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice
Essy Mozaffari, Aastha Chandak, Robert Gottlieb, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 12, pp. 1626-1634
Open Access | Times Cited: 31
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic
Valerie W. Shurtleff, M. E. Layton, Craig A. Parish, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3935-3958
Closed Access | Times Cited: 7
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 6
Seroconversion and dynamics of IgG anti-SARS-CoV-2 antibodies during the pandemic: A two-month observation cohort study on the population of Sleman in Indonesia
Jajah Fachiroh, Septi Kurnia Lestari, Dewi Kartikawati Paramita, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316360-e0316360
Open Access
An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses
Theocharis Tsoleridis, Chengcheng Fan, Emily J. Park, et al.
(2025)
Open Access
Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review
Manuela H Gschwend, Anthony M. Marchese, Dirk Poelaert, et al.
Vaccine (2025) Vol. 49, pp. 126777-126777
Open Access
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Juan G. Ripoll, Sidna M. Tulledge‐Scheitel, Anthony A. Stephenson, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 5
Unveiling COVID‐19 treatment strategies for immunocompromised individuals: Therapeutic innovations and latest findings
Li‐Teh Liu, Jih‐Jin Tsai
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 4
How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic
Michael Boeckh, Steven A. Pergam, Ajit P. Limaye, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 4
From Emergence to Endemicity: A Comprehensive Review of COVID-19
Roopa Naik, Sreekant Avula, Sujith K Palleti, et al.
Cureus (2023)
Open Access | Times Cited: 11
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
Hilde S Ørbo, K. H. Bjørlykke, Joseph Sexton, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e003545-e003545
Open Access | Times Cited: 3
Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity
Raymund R. Razonable
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History
Paulina Nazaruk, Ignacy Tkaczyk, Marta Monticolo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1380-1380
Open Access | Times Cited: 8
Employee investigation and contact tracing program in a pediatric cancer hospital to mitigate the spread of COVID-19 among the workforce, patients, and caregivers
Diego R. Hijano, Sandra R. Dennis, James M. Hoffman, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2
Anti-SARS-CoV2 serological profile and associated factors in adults living with HIV followed at Departmental and Teaching Hospital of Borgou in 2022.
Attinsounon Cossi Angelo, Dovonou Comlan Albert, Alidjinou Kazali, et al.
Journal of Infectiology (2024) Vol. 6, Iss. 2, pp. 5-10
Open Access | Times Cited: 2
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
Ilias Ι. Siempos, André C. Kalil, Drifa Belhadi, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102472-102472
Open Access | Times Cited: 2
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis
Sonphet Chirasuthat, Yanisa Ratanapokasatit, Kunlawat Thadanipon, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv40009-adv40009
Open Access | Times Cited: 2
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
Katharine Valéria Saraiva Hodel, Bianca Sampaio Dotto Fiuza, Rodrigo Souza Conceição, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 807-807
Open Access | Times Cited: 2
The Association of Physical Distancing Behaviors to Avoid COVID-19 with Health-Related Quality of Life in Immunocompromised and Non-Immunocompromised Individuals: The Patient-Informed Protocol for the Observational, Cross-Sectional EAGLE Study (Preprint)
Paul Williams, Timothy A. Herring, Renata Yokota, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e52643-e52643
Open Access | Times Cited: 2
What do we know about covid in immunocompromised people?
Katharine Lang
BMJ (2023), pp. p1612-p1612
Open Access | Times Cited: 7
An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine
Siying Hu, Dan Luo, Qikui Zhu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants
Vijay Subramanian
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S34-S45
Open Access | Times Cited: 6
Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza
Ting-Hui Liu, Po‐Yu Huang, Jheng‐Yan Wu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey
Alessandro Visentin, E. Pickavance, Rafael San Juan, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 2
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top